These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 27079511
1. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals. Downing NS, Shah ND, Neiman JH, Aminawung JA, Krumholz HM, Ross JS. Trials; 2016 Apr 14; 17():199. PubMed ID: 27079511 [Abstract] [Full Text] [Related]
6. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. Wissing MD, Kluetz PG, Ning YM, Bull J, Merenda C, Murgo AJ, Pazdur R. Cancer; 2014 Oct 01; 120(19):3025-32. PubMed ID: 24965506 [Abstract] [Full Text] [Related]
9. Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals. Idris MY, Fitzsimmons WE, Pemu P. Ther Innov Regul Sci; 2024 Jan 01; 58(1):175-183. PubMed ID: 37872439 [Abstract] [Full Text] [Related]
10. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis. Allison K, Patel DG, Greene L. JAMA Netw Open; 2021 May 03; 4(5):e218348. PubMed ID: 34003274 [Abstract] [Full Text] [Related]
11. Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019. Dhodapkar M, Zhang AD, Puthumana J, Downing NS, Shah ND, Ross JS. JAMA Netw Open; 2021 Jun 01; 4(6):e2113224. PubMed ID: 34110392 [Abstract] [Full Text] [Related]
16. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. Tahhan AS, Vaduganathan M, Greene SJ, Alrohaibani A, Raad M, Gafeer M, Mehran R, Fonarow GC, Douglas PS, Bhatt DL, Butler J. JAMA Cardiol; 2020 Jun 01; 5(6):714-722. PubMed ID: 32211813 [Abstract] [Full Text] [Related]
19. Premarket Pivotal Trial End Points and Postmarketing Requirements for FDA Breakthrough Therapies. Mooghali M, Wallach JD, Ross JS, Ramachandran R. JAMA Netw Open; 2024 Aug 01; 7(8):e2430486. PubMed ID: 39190303 [Abstract] [Full Text] [Related]